Wei Li - Profile and Investment Details

Investor Profile

Wei Li is a Venture Capital, Angel/Individual, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Syros Pharmaceuticals, LifeMine Therapeutics, XW Laboratories, Forerunner Medical, Ivenix, Medeor Therapeutics, Antengene Corporation, Refuge Biotechnologies, Avelas Biosciences, Nutrinia, Hua Medicine, Tunitas Therapeutics, Lumo Bodytech, 51Talk, IMPACT Therapeutics, Adagene, TenNor Therapeutics, UNITY Biotechnology, 23andMe, Hommily, AltheaDxCStone Pharmaceuticals, Innovent Biologics, Twist Bioscience, IDEAYA Biosciences, Vivace Therapeutics, . Over time, Wei Li has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Wei Li is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, E-commerce, Women Founded, Life Science, Biotechnology, Consumer Health, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Consumer Internet, Social Media, Digital Health, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Wei Li, as their portfolio suggests a familiarity and interest in this area.

Understanding Wei Li’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.